Home > Boards > US Listed > Medical - Drugs > MyMD Pharmaceuticals Inc (MYMD)

MYMD up strongly on a day when all

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
knuts4oe Member Profile
 
Followed By 3
Posts 594
Boards Moderated 0
Alias Born 06/26/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 5:31:32 PM
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan Business Wire - 9/13/2021 10:00:00 AM
MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15 Business Wire - 9/9/2021 10:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2021 4:38:53 PM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma Business Wire - 8/24/2021 10:17:00 AM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases Business Wire - 8/10/2021 2:30:00 PM
MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine Business Wire - 8/10/2021 10:30:00 AM
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study Business Wire - 8/5/2021 10:30:00 AM
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shows Commonality in Comparative Study with FDA-Approved Anti-Inflammatory and Anti-Autoimmune Drugs Used for Arthritis, Colitis and Dermatitis Business Wire - 7/27/2021 9:15:00 AM
MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1 Business Wire - 7/7/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 5:00:55 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/2/2021 4:01:25 PM
MyMD Pharmaceuticals Set to Join Russell Microcap® Index Business Wire - 6/7/2021 10:02:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/18/2021 6:11:59 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/18/2021 6:07:21 AM
MyMD Pharmaceuticals Appoints David Rini, Professor at the Johns Hopkins School of Medicine, to Scientific Advisory Board Business Wire - 5/17/2021 9:00:00 AM
MyMD Pharmaceuticals Schedules Business Update Conference Call Business Wire - 5/12/2021 9:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/12/2021 6:05:34 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 5/11/2021 4:28:20 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/28/2021 5:26:41 PM
Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Dr... Business Wire - 4/28/2021 10:13:00 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 4/27/2021 6:02:14 AM
MyMD Pharmaceuticals Announces Issuance of Allowance from United States Patent & Trademark Office for Synthetic Cannabinoid C... Business Wire - 4/22/2021 9:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/22/2021 6:04:24 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/21/2021 5:55:31 PM
knuts4oe   Tuesday, 06/15/21 04:07:30 PM
Re: None
Post # of 146 
MYMD up strongly on a day when all major indices were down and NASDAQ down the most percentagewise! What is it trying to tell us!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences